3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
Emeline TabouretJulia FurtnerThomas GraillonAntonio SilvaniEmilie Le RhunRiccardo SoffiettiGiuseppe LombardiJuan Manuel Sepúlveda-SánchezPetter BrandalMartin BendszusVassilis GolfinopoulosThierry GorliaMichael WellerFelix SahmWolfgang WickMatthias PreusserPublished in: Neuro-oncology (2024)
Tumor 3DVGR classification may be helpful to identify early signals of treatment activity in meningioma clinical trials.